Literature DB >> 11431399

Menopause and hormone-replacement therapy: Part 2. Hormone-replacement therapy regimens.

S Ratner1, D Ofri.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11431399      PMCID: PMC1071462          DOI: 10.1136/ewjm.175.1.32

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


× No keyword cloud information.
  1 in total

1.  Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study Group.

Authors:  H K Genant; J Lucas; S Weiss; M Akin; R Emkey; H McNaney-Flint; R Downs; J Mortola; N Watts; H M Yang; N Banav; J J Brennan; J C Nolan
Journal:  Arch Intern Med       Date:  1997 Dec 8-22
  1 in total
  4 in total

1.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

2.  Serum metabolomic profiles associated with postmenopausal hormone use.

Authors:  Victoria L Stevens; Ying Wang; Brian D Carter; Mia M Gaudet; Susan M Gapstur
Journal:  Metabolomics       Date:  2018-07-06       Impact factor: 4.290

Review 3.  Premature Ovarian Insufficiency: Past, Present, and Future.

Authors:  Seung Joo Chon; Zobia Umair; Mee-Sup Yoon
Journal:  Front Cell Dev Biol       Date:  2021-05-10

4.  Estrogenic activity of capsule coffee using the VM7Luc4E2 assay.

Authors:  Junichi R Sakaki; Melissa M Melough; Cathy Z Yang; Anthony A Provatas; Christopher Perkins; Ock K Chun
Journal:  Curr Res Toxicol       Date:  2021-05-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.